ResMed Inc

Company Profile

ResMed Inc had its IPO on 1995-06-02 under the ticker symbol RMD.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. ResMed Inc has a staff strength of 10,140 employees.

Stock update

Shares of ResMed Inc opened at $151.51 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $147.49 - $152.19, and closed at $148.97.

This is a -1.68% slip from the previous day's closing price.

A total volume of 1,346,107 shares were traded at the close of the day’s session.

In the last one week, shares of ResMed Inc have slipped by -6.42%.

ResMed Inc's Key Ratios

ResMed Inc has a market cap of $22.28 billion, indicating a price to book ratio of 9.4242 and a price to sales ratio of 8.6911.

In the last 12-months ResMed Inc’s revenue was $4.22 billion with a gross profit of $2.39 billion and an EBITDA of $1.29 billion. The EBITDA ratio measures ResMed Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ResMed Inc’s operating margin was 27.28% while its return on assets stood at 12.15% with a return of equity of 23.97%.

In Q2, ResMed Inc’s quarterly earnings growth was a positive 17.3% while revenue growth was a positive 22.7%.

ResMed Inc’s PE and PEG Ratio

Forward PE

35.3357

Trailing PE

24.8377

PEG

1.7408

Its diluted EPS in the last 12-months stands at $6.1 per share while it has a forward price to earnings multiple of 35.3357 and a PEG multiple of 1.7408. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ResMed Inc’s profitability.

ResMed Inc stock is trading at a EV to sales ratio of 9.1259 and a EV to EBITDA ratio of 27.4632. Its price to sales ratio in the trailing 12-months stood at 8.6911.

ResMed Inc stock pays annual dividends of $1.76 per share, indicating a yield of 1.3% and a payout ratio of 27.91%.

Balance sheet and cash flow metrics

Total Assets

$6.75 billion

Total Liabilities

$758.53 million

Operating Cash Flow

$-1159845000.00

Capital Expenditure

$38.73 million

Dividend Payout Ratio

27.91%

ResMed Inc ended 2024 with $6.75 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $6.75 billion while shareholder equity stood at $4.13 billion.

ResMed Inc ended 2024 with $0 in deferred long-term liabilities, $758.53 million in other current liabilities, 588000.00 in common stock, $4.25 billion in retained earnings and $2.77 billion in goodwill. Its cash balance stood at $227.89 million and cash and short-term investments were $227.89 million. The company’s total short-term debt was $31,821,000 while long-term debt stood at $1.43 billion.

ResMed Inc’s total current assets stands at $2.37 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $704.91 million compared to accounts payable of $150.76 million and inventory worth $998.01 million.

In 2024, ResMed Inc's operating cash flow was $-1159845000.00 while its capital expenditure stood at $38.73 million.

Comparatively, ResMed Inc paid $0.28 in dividends in 2024.

Other key metrics

Current Trading Price

$148.97

52-Week High

$242.4201

52-Week Low

$146.44

Analyst Target Price

$250.45

ResMed Inc stock is currently trading at $148.97 per share. It touched a 52-week high of $242.4201 and a 52-week low of $242.4201. Analysts tracking the stock have a 12-month average target price of $250.45.

Its 50-day moving average was $190.06 and 200-day moving average was $211.42 The short ratio stood at 1.34 indicating a short percent outstanding of 0%.

Around 129.6% of the company’s stock are held by insiders while 6679.5% are held by institutions.